# Predicting Cancer Risk With Digital and Molecular Markers

> **NCT06962670** · NA · RECRUITING · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 1250 (estimated)

## Conditions studied

- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gynecologic Cancer

## Interventions

- **OTHER:** Biomaterial collection
- **OTHER:** BayPass mobile application

## Key facts

- **NCT ID:** NCT06962670
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-14
- **Primary completion:** 2025-09
- **Final completion:** 2025-12
- **Target enrollment:** 1250 (ESTIMATED)
- **Last updated:** 2025-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06962670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06962670, "Predicting Cancer Risk With Digital and Molecular Markers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06962670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*